ARTICLE | Company News
Ligand, ParinGenix deal
July 6, 2009 7:00 AM UTC
ParinGenix received exclusive rights to three of Ligand's U.S. patents covering desulfated heparin compounds for the potential treatment of chronic obstructive pulmonary disease (COPD) and other indic...